As drug approvals dive in 2016, returns on R&D deteriorate

LONDON, Dec 13 (Reuters) - The global pharmaceuticals

industry is set to win the lowest annual number of new drug

approvals this year since 2010 and a new report on Tuesday

suggests drugmakers'...

Read more